Bank of New York Mellon
IFRX icon

Bank of New York Mellon’s InflaRx IFRX Stock Holding History

Bank of New York Mellon’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-8,065
Closed -$277K – 4251
2018
Q3 		$277K Buy
+8,065
New +$260K ﹤0.01% 3845

Other funds holding IFRX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Bank of New York Mellon's IFRX Position: Q4 2018 in Review

Bank of New York Mellon sold out of InflaRx (IFRX) in Q4 2018, closing a stake of 8,065 shares — an estimated $277K sold.

Bank of New York Mellon first reported a position in IFRX in Q3 2018 and held it in 1 quarter. The position peaked at $277K in Q3 2018. 34 funds tracked by Wall St. Rank hold IFRX as of Q4 2018.

  • Bank of New York Mellon reported no remaining InflaRx position as of Q4 2018 after selling out during the quarter.
  • Bank of New York Mellon sold 8,065 InflaRx shares in Q4 2018, an estimated $277K.
  • Bank of New York Mellon first reported a position in InflaRx in Q3 2018 and held it in 1 quarter.
  • Bank of New York Mellon's InflaRx position peaked at $277K in Q3 2018.
  • 34 funds tracked by Wall St. Rank held InflaRx as of Q4 2018.

Based on Bank of New York Mellon's 13F filing for Q4 2018, filed 11 Feb 2019.